Cargando…
MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity
BACKGROUND: Cancer of the ovary is mostly discovered at a late stage and cannot be removed by surgery alone. Therefore surgery is usually followed by adjuvant chemotherapy. However, few reliable biomarkers exist to predict response to chemotherapy of ovarian cancer. Previously, we could demonstrate...
Autores principales: | Droeser, Raoul A., Mechera, Robert, Däster, Silvio, Weixler, Benjamin, Kraljević, Marko, Delko, Tarik, Güth, Uwe, Stadlmann, Sylvia, Terracciano, Luigi, Singer, Gad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988007/ https://www.ncbi.nlm.nih.gov/pubmed/27531373 http://dx.doi.org/10.1186/s12885-016-2673-7 |
Ejemplares similares
-
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
por: Ramser, Michaela, et al.
Publicado: (2018) -
Tumor Infiltration by OX40+ Cells Enhances the Prognostic
Significance of CD16+ Cell Infiltration in Colorectal Cancer
por: Haak, Fabian, et al.
Publicado: (2020) -
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy
por: Walther, Fabio, et al.
Publicado: (2022) -
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival
por: Lalos, Alexandros, et al.
Publicado: (2021) -
Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial
por: Kraljević, Marko, et al.
Publicado: (2017)